chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vaccines given 5/10/04. Patient/Mom return 5/11/04 with complaints of right leg redness/swelling. Examination of left thigh with 2 lesions approximately 2cmx1cm, erythematous edema, warm to touch. Patient started on Amox 125 and Tylenol. Follow up 5/17/04: resolved redness, decreased swelling.
Headache started the afternoon after the injection and I still gave a headache one month later. However, it is getting a little better  Just want to make this known
anxious & numbness to the back of the head.   Medics present.  Hx of anxiety & Abhb.    Symptoms resolved with comfort measures.   BP 114/72- HR=64
Pt started to feel dizzy after approx 15 minutes  of receiving the vaccine, high blood pressure, swollen tongue, difficulty swallowing. EMS was called and pt was transported to hospital ER for further evaluation.  Was released from hospital a couple hours later and feeling better since vaccine administration.
2 pm- received shot 8 pm (estimate)- hips and back began to ache (hips worse than back), fatigue, arm was very sore 10/10:30 pm- went to bed  Saturday 3/27 8:30/9 am- woke up fatigued, achy all over (mostly joints), stabbing headache, chills (took a shower, that helped with the chills. 9/9:30 am- took two Tylenol still fatigued, chills on and off, headache lighter after Tylenol as were aches, but still there. Arm still very sore 10 am-1 pm- intermittent sleeping, chills, woke overly hot (did not take temp, but this lasted for 20-30 min) arm still very sore 2 pm- achy, headache returned, fatigued, arm still very tender/sore, took two Tylenol, symptoms lessened a little but still present through the day fatigue still constant 7-9 pm- aches and headache return, took bath, helped with aches when in bath 9:30/10 pm- fell asleep and slept through the night  Sunday 3/28 9 am- Woke up with stabbing headache though aches were much better (but still present) slight fatigue. Took 2 Tylenol Made symptoms almost unnoticable 2 pm- stabbing headache returned, took Tylenol and felt mostly fine the rest of the day though fatigued. The very sore arm continued until Tuesday.
Next day- Pain and redness; Next day- Pain and redness; Same day- pain on the injection area.; Next 10-12 days: Itchy, swelling and redness on the injection area.; Next 10-12 days: Itchy, swelling and redness on the injection area.; Next 10-12 days: Itchy, swelling and redness on the injection area.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 26 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 06Aug2021 11:30 (Lot number: FA7485) at the age of 26 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "White eggs" (unspecified if ongoing); "known allergies: Nuts" (unspecified if ongoing); "known allergies: Wheat" (unspecified if ongoing); "known allergies: Soybean" (unspecified if ongoing); "known allergies: Sesame Seed" (unspecified if ongoing); "known allergies: Shrimps" (unspecified if ongoing); "known allergies: Scallops" (unspecified if ongoing); "known allergies: Salmon" (unspecified if ongoing); "known allergies: Mite" (unspecified if ongoing); "known allergies: mold" (unspecified if ongoing); "known allergies: pollen" (unspecified if ongoing). Concomitant medication(s) included: BIOTIN; VITAMIN C [ASCORBIC ACID]. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 06Aug2021 13:00, outcome "recovered" (Aug2021), described as "Same day- pain on the injection area."; PAIN (non-serious), ERYTHEMA (non-serious) all with onset 07Aug2021, outcome "recovered" (Aug2021) and all described as "Next day- Pain and redness"; PRURITUS (non-serious), VACCINATION SITE SWELLING (non-serious), VACCINATION SITE ERYTHEMA (non-serious) all with onset Aug2021, outcome "recovered" (Aug2021) and all described as "Next 10-12 days: Itchy, swelling and redness on the injection area.".   Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. List of any other medications the patient received within 2 weeks of vaccination included Biotin, Vitamins, Vitamin C. Prior to vaccination, the patient was not diagnosed with COVID-19.Since the vaccination, the patient has not been tested for COVID-19.  Follow-Up (01Sep2021): Follow-up attempts are completed. No further information is expected.  No follow-up attempts are possible. No further information is expected. Reporter's Comments: ~~~
Parent discovered patient with spotty red rash on abdomen, back, face, and upper and lower extremities. Patient was brought to the clinic with rash symptoms but unsure if it is related to vaccination received on 08/15/2014. Patient received Hepatitis A, MMR, an varicella. Patient will return to office in 2 business days for re-evaluation of symptoms.
NauseaVomiting Nausea and weakness started about 10 minutes post vaccination Narrative:  Employee sent to ER for firther evaluation
I got the ovid 3 weeks ago; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (I got the ovid 3 weeks ago) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (I got the ovid 3 weeks ago). At the time of the report, COVID-19 (I got the ovid 3 weeks ago) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No treatment medications were reported.
No adverse effect reported; Patient received improperly stored VARIVAX; This spontaneous report was received from a certified medical assistant and refers to a 56 week old patient of unknown gender. The patient's medical history and concurrent conditions were not reported.   On 05-SEP-2019, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX), lot # S002874, expiration date 29-JAN-2021, for prophylaxis (dose, dose number, and route were not provided). The varicella virus vaccine live (oka/merck) (VARIVAX) was reconstituted with properly stored sterile diluent. No adverse effect reported.   The temperature excursion was from 6°F to 14°F (10.2°F, multiple) for 50 minutes. There were no previous temperature excursions. Digital data logger involved.   This is one of several cases received from the same reporter.; Sender's Comments:  US-009507513-1909USA005231: US-009507513-1909USA005078: US-009507513-1909USA005119: US-009507513-1909USA005129: US-009507513-1909USA005134: US-009507513-1909USA005139: US-009507513-1909USA005220: US-009507513-1909USA005223: US-009507513-1909USA005365: US-009507513-1909USA005375: US-009507513-1909USA005424: US-009507513-1909USA005468: US-009507513-1909USA005525:
9/16/20 Developed a low grade fever 99.5 and sores in mouth that lasted until 9/20/20. 9/17/20 had swollen lymph nodes bilateral clavicle to neck and developed hives  on bilateral ankles. Went to Urgent Care, RX oral Prednisone oral for 10 days and topical  steroid cream. 9/22/20 went to Dermatologist RX to continue Prednisone and topical steroid cream, Zyrtec, Allegra, Hydroxizine, Tagamet
Pain in affected arm; persistent.  To whom it may concern, I reacently filed report with you on this pt.  Pt did not have reaction to vaccine she has been diagnosed with shingles.  Any questions feel free to call me.
Blood Pressure was very high the next day when I took it. My heartbeat was racing like crazy also.  First time I took my BP it was 161/100 that was around 8 pm. The second time I took it it was 156/106 and that was around 1130 pm. The next day when I woke up and took my BP again it was back to my normal BP 126/78. I have never had that high of a BP before even when I was pregnant with my 3 kids.
LIP SWELLING, HIVES, ERYTHEMA OF TRUNK, EMESIS WITHIN 15 MIN. OF VACCINATION.  GIVEN EPINEPHRINE SUBCUTANEOUS, SOLUMEDROL AND BENADRYL IM, ALBUTEROL NEB TREATMENT.  WENT TO ER AFTER 30 MIN. OF REACTION.  GOOD PULSE OX. MONITORING AND STABLE VITALS.  TACHYCARDIA RESOLVED.  ALL ABOVE SX. RESOLVED.  GIVEN IV FLUID HYDRATION ONLY IN THE ER.
Sore throat; Flu like symptoms; Sleeping all day; Sweating; Chills; Headache; Fever; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Sore throat), INFLUENZA LIKE ILLNESS (Flu like symptoms), SOMNOLENCE (Sleeping all day), HYPERHIDROSIS (Sweating) and CHILLS (Chills) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021B21A-1 and 008C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma and Allergy NOS. Concomitant products included IRON for an unknown indication.   On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Jun-2021, the patient experienced OROPHARYNGEAL PAIN (Sore throat), INFLUENZA LIKE ILLNESS (Flu like symptoms), SOMNOLENCE (Sleeping all day), HYPERHIDROSIS (Sweating), CHILLS (Chills), HEADACHE (Headache) and PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. On 05-Jun-2021, OROPHARYNGEAL PAIN (Sore throat), INFLUENZA LIKE ILLNESS (Flu like symptoms), SOMNOLENCE (Sleeping all day), HYPERHIDROSIS (Sweating), CHILLS (Chills), HEADACHE (Headache) and PYREXIA (Fever) had resolved.            Concurrent medications reported included asthma and allergy medications but stopped since the onset of events. The patient continued to take iron event after the onset of events. The patient experienced events 12 to 18 hours post second dose of vaccine administration and took treatment medications alternatively.   This case was linked to MOD-2021-216667 (Patient Link).
Mom called around 11:30 am the next day (11-02-22) reporting that there was small bump around the injection site-plus redness
Fatigue following the second dose only.; This is a spontaneous report from a non-contactable consumer (patient). A 25-year-old non pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection Batch/Lot number: EL3248, Expiration Date was not reported), via an unspecified route of administration administered in right arm on 03Feb2021 16:00 (at the age of 25-year-old) as 2nd dose, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient historical vaccine included first dose of BNT162B2 (Batch/Lot number: EL3248) via an unspecified route of administration administered in right arm on 13Jan2021 04:00 pm for COVID-19 immunization. The patient previously took zofran [ondansetron] on an unspecified date and experienced drug allergies (hypersensitivity). No other vaccine received in four weeks. Patient had not been diagnosed with COVID-19 prior to vaccination and had not tested positive since the vaccination. On 04Feb2021 the patient experienced fatigue following the second dose only. No treatment received for the AE. The outcome of the events was reported as recovered.  No follow-up attempts are possible. Information regarding batch/lot number cannot be obtained.
I experienced chills and a fever of 103.4 beginning the night of the shot headache and nausea. The next day the fever had started to decrease to 101 then 100 within 24 hours. I also had extreme exhaustion. Starting Friday I began to feel somewhat better but still maintained a low grade fever of 99.5. The injection site is swollen and hot to the touch with a red welt about 4 inches in diameter. This is very painful. In general I believe I am on the mend. But not looking forward to round 2. I have been taking TYLENOL.
Right Arm redness, swelling , rash started about 1 week after shot.  It started and red and itchy and then turned to almost a bruise and then back to red and swollen and itchy
BREAKTHROUGH COVID: FULLY VACCINATED WITH BOOSTER. Pt states he tested positive for COVID 3 wks ago, since than pt has had a cough, and increase SOB at night. DX post COVID pneumonia. PT REQUIRED 2L OF OXYGEN. Patient was given nebulizers, ceftriaxone, azithromycin, Decadron for presumed post viral pneumonia. Patient is being admitted for further evaluation.  Upon further evaluation, patient states that he ha5-year-old gentleman who presented with complaint of shortness of breath, cough and dyspnea on exertion. Chest imaging revealed evidence of likely edema.  Patient responded well to IV Lasix. Echocardiogram revealed decreased ejection fraction roughly 35-40% EF.s noticed that his heart rate had been elevated since COVID a and his blood pressure has been uncontrolled.
Felt warm; Pink rash near the injection site; Swelling on face and cheek; Face was flushed; A spontaneous report was received from a consumer concerning an 80-year-old, female patient, who received Moderna's covid-19 vaccine and experienced swelling on the face and cheek(swelling face), flushing of face(flushing), felt warm (feeling hot) and pink rash near the injection site(rash erythematous).    The patient's medical history was not provided. Patient was allergic to Penicillin and Augmentin. Concomitant medications included paroxetine 30mg, hydrochlorothiazide 12.5mg, rosuvastatin, lisinopril, Tylenol, vitamin D, alprazolam and aspirin 81mg.   On 25 Feb 2021, prior to the onset of events, the patient received their second of two planned doses of mRNA-1273 (Batch number:013M20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.   On 25 Feb 2021, after the vaccination,patient started experiencing swelling on her face and cheek.Her face was flushed.On 26 Feb 2021, she felt warm and pink rash appeared near the injection site.She has not received any treatment for her symptoms and the symptoms were ongoing.  Action taken with mRNA-1273 in response to the event was not applicable.  Outcome of the events, swelling on the face and cheek, flushing of face, felt warm and pink rash near the injection site, were considered as not resolved.
By midnight after getting the shot, my arm was extremely painful. I iced it through the night, but it didn't help that much. Then the next morning, was very nauseous and started having diarrhea. Remained nauseous and continued having diarrhea for 2 1/2 days. Arm was sore for 3 days. Then, the diarrhea slowed down, recurs about once a day, but have continued having regular bouts of nausea, especially after eating or when doing something more physically active (skiing, snowshoeing, walking the dogs, swimming). And last night, 10 days after receiving the vaccine, a slightly sore, itchy hive the size of a 1/2 dollar appeared at the injection site and slight soreness returned. No temperature during any of it so far.
I developed tinnitus in both ears sometime in the week following the vaccine, my 4th shot. It is now two months later and the tinnitus is still there
Information has been received from a male doctor of medical dentistry with rheumatoid arthritis and unknown allergies, who on 6/21/02 was vaccinated with a hep a vaccine, but does not know if he received hep A virus vaccine inactivated or hep A vaccine (Havrix). Concomitant therapy included Enbrel and Remicade. On an unknown date in 2002 the pt developed diarrhea, chills, fever and weakness. Unspecified medical attention was sought. Additional info has been requested.
suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was recovering/resolving.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by the patient's wife. The age at vaccination was not reported. After receiving Shingles vaccine, the patient got shingles. At the time of reporting, the patient was recovering. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation of shingles were not provided.
Pain in shoulder (muscle around injection site) that was so intense it was very difficult to raise arm above chest height.  Began within 2 hours of injection and continued well into the following evening.
Second Pfizer COVID vaccine given 2/12/2021. Developed symptoms one day after 2nd Pfizer vaccination with headache, body aches, chills, followed by abdominal pain, vomiting and diarrhea over the next 3 days, then became confused per wife so he came to ED for evaluation on 3/16/2021 and evaluated by me.   Also had black stools and vomiting blood. Diagnoses: Septic shock, Gastrointestinal Bleeding with severe blood loss,  Hepatitis with Hepatic Encephalopathy, Liver cirrhosis.  Admitted to hospital 2/16/2021-discharged 2/21/2021.  Since symptoms developed day after vaccination, I am compelled to report.
This spontaneous report was received from an other health professional refers to a female infant patient of unknown age. On an unknown date, the infant mother was vaccinated with VARIVAX (Merck) (dose, route and frequency was not reported). On an unknown date, 45 days after infant mother received VARIVAX (Merck), the infant contracted chickenpox. The patient was sought medical attention and saw the physician. On an unknown date, the infant had a generalized rash, no fever and no complications. The infant had no known exposure of wild type varicella and mother did not exhibit any signs of a rash. On an unknown date cultured a vesicle and identified varicella virus. The outcome of the event chickenpox and generalized rash was unknown. The reporter did not provide the causality between the event and the suspect drug. Additional information has been requested.
A report has been received from a Health Professional concerning a 53 year old, female subject, who had been receiving FLUMIST (Intranasal). FLUMIST (Intranasal) started on an unknown date. The medical assistant reported that a 53 year old female came with daughter and stated both wanted FLUMIST so they accidentally gave FLUMIST to her. She had not experienced any adverse symptoms. The outcome of the event of administered FLUMIST to a 53 year old is unknown. The report was considered to be non-serious.
Injection site pain which required doctor visit. Pain began 1 day following administration. MD recommended TYLENOL and cold compress.
This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Felt a in knot in the left arm) and CONTUSION (Bruise in the  left arm) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002C21A) for COVID-19 vaccination. No Medical History information was reported. On 07-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-May-2021, the patient experienced PERIPHERAL SWELLING (Felt a in knot in the left arm) and CONTUSION (Bruise in the  left arm). At the time of the report, PERIPHERAL SWELLING (Felt a in knot in the left arm) and CONTUSION (Bruise in the  left arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. No treatment information was provided. This case was linked to US-MODERNATX, INC.-MOD-2021-137973 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2021-137973:
This case was reported by a nurse via call center representative and described the occurrence of extensive swelling of vaccinated limb in a 18-month-old female patient who received FLULAVAL QUADRIVALENT (batch number 7PL77, expiry date 31st May 2018). On 31st October 2017 10:52, the patient received FLULAVAL QUADRIVALENT .5 ml. In November 2017, 20 hrs after receiving FLULAVAL QUADRIVALENT, the patient experienced extensive swelling of vaccinated limb, injection site erythema and injection site tenderness. On an unknown date, the outcome of the extensive swelling of vaccinated limb was recovering/resolving and the outcome of the injection site erythema and injection site tenderness were recovered/resolved. The reporter considered the extensive swelling of vaccinated limb, injection site erythema and injection site tenderness to be related to FLULAVAL QUADRIVALENT. Rerun narrative: Additional details were provided as follows: The patient received FLULAVAL QUADRIVALENT on the left thigh and about "20 to 24 hours" after receiving FLULAVAL QUADRIVALENT, the patient experienced redness, swelling and tenderness of entire left thigh. The patient was taken to the emergency room and a follow-up physician's office visit was conducted; no further treatment was performed at either facility. On 3rd November 2017, a follow-up phone call was placed by the healthcare professional office to the patient and that time the patient's mother reported the symptoms of redness and tenderness had completely resolved, patient was up and walking around normal, however there was still some mild swelling. The healthcare professional reported no other vaccines were administered that day and believe the symptoms were a direct result of the FLULAVAL QIV vaccine. No further information was reported at this time regarding the event.
Shingles (mild case) 12/20/2020, followed immediately by onset of Grover's Disease affecting torso back and chest on previously sun-damaged skin excluding area of shingles (C4 dermatome.)  I would have thought the sequence and frequency were coincidental, but have found others with Grover's Disease who have had the exact same sequence of events. The disability referred to below is a quality of life issue - itching, interfering with sleep and activities, common to others with Grovers Disease.
Non productive cough; diarrhea; This is a spontaneous report from a contactable other healthcare professional (HCP). A 36-year-old male patient received 1 dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EJ1685) intramuscular on right arm on 23Dec2020 03:15PM, single dose for COVID-19 immunization at 36-year-old. Medical history included: allergies: promethazine hydrochloride (PHENERGAN). Prior to vaccination, the patient did not diagnose with COVID-19. Concomitant medication was not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 24Dec2020, 05:00AM, the patient experienced non-productive cough, diarrhea. No treatment received. Since the vaccination, the patient had not been tested for COVID-19. Action taken for BNT162B2 was not applicable. Outcome of the events was not resolved. It was reported as non-serious.  No follow-up attempts are possible. No further information is expected.
TWINRIX #1 given IM Rt deltoid on 3/7/16. Client states on 3/10/16 she developed hives to entire body and throat began to swell shut. Reports that she went to ER for evaluation.
Client was seen in Travel clinic.  Was given Hepatitis A and oral Typhoid Fever vaccine (to take at home).  Client took first of 4 capsules on Tuesday afternoon on an empty stomach.   She started coughing sometime in the afternoon, and went to work.  At 5 pm, she was sent home from work.  On Wednesday afternoon, she went to Urgent Care at 3:50 pm, for Rapid heart beat, SOB, shaking all over, and cold and numbness to all extremities. Uncertain when symptoms started on 5/26/04.